✦ LIBER ✦

Angiogenesis in Non-Small Cell Lung Cancer

✍ Scribed by Kim, Tracy E. ;Murren, John R.

Book ID: 120885389
Publisher: Springer-Verlag
Year: 2002
Tongue: English
Weight: 218 KB
Volume: 1
Category: Article
ISSN: 1175-6365
DOI: 10.1007/BF03256626

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Angiogenesis in non-small cell lung canc

Angiogenesis in non-small cell lung cancer

✍ Thomas A D’Amico 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Neural-cadherin expression associated wi

Neural-cadherin expression associated with angiogenesis in non-small-cell lung cancer patients

✍ Nakashima, T; Huang, C; Liu, D; Kameyama, K; Masuya, D; Kobayashi, S; Kinoshita, 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 187 KB

Correlation between cyclooxygenase-2 and

Correlation between cyclooxygenase-2 and tumor angiogenesis in non-small cell lung cancer

✍ Kim, Hyung-Seok; Youm, Hyung-Roul; Lee, Ji-Shin; Min, Kyung-Whan; Chung, Jae-Hun 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 382 KB

Stromal aminopeptidase N expression: cor

Stromal aminopeptidase N expression: correlation with angiogenesis in non-small-cell lung cancer

✍ Shinya Ito; Ryo Miyahara; Rei Takahashi; Shinjiro Nagai; Kazumasa Takenaka; Hiro 📂 Article 📅 2009 🏛 Springer Japan 🌐 Japanese ⚖ 292 KB

Molecular mechanisms of angiogenesis in

Molecular mechanisms of angiogenesis in non-small cell lung cancer, and therapeutics targeting related molecules

✍ Seiji Yano; Yasuhiko Nishioka; Hisatsugu Goto; Saburo Sone 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB

Potential role of bcl-2 as a suppressor

Potential role of bcl-2 as a suppressor of tumour angiogenesis in non-small-cell lung cancer

✍ Michael I. Koukourakis; Alexandra Giatromanolaki; Kenneth J. O'Byrne; Ruth M. Wh 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 231 KB 👁 2 views

It has been reported that genes regulating apoptosis may play a role in tumoral angiogenesis. This study examined the relationship between tumour vascularization, a measure of tumour angiogenesis, and bcl-2 and p53 expression in operable non-small-cell lung cancer (NSCLC). The relationship between b